UBS Group
SIBN icon

UBS Group’s SI-BONE Inc SIBN Stock Holding History

UBS Group’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609K Sell
48,251
-56,480
-54% -$884K ﹤0.01% 5938
2025
Q4 		$2.07M Buy
104,731
+89,105
+570% +$1.55M ﹤0.01% 4947
2025
Q3 		$230K Sell
15,626
-107,846
-87% -$1.76M ﹤0.01% 6592
2025
Q2 		$2.32M Buy
123,472
+70,682
+134% +$1.17M ﹤0.01% 4655
2025
Q1 		$741K Sell
52,790
-75,779
-59% -$1.22M ﹤0.01% 5541
2024
Q4 		$1.8M Buy
128,569
+109,094
+560% +$1.47M ﹤0.01% 4820
2024
Q3 		$272K Sell
19,475
-16,833
-46% -$253K ﹤0.01% 5646
2024
Q2 		$469K Sell
36,308
-32,183
-47% -$460K ﹤0.01% 5050
2024
Q1 		$1.12M Buy
68,491
+11,137
+19% +$210K ﹤0.01% 4507
2023
Q4 		$1.2M Buy
57,354
+25,522
+80% +$472K ﹤0.01% 4335
2023
Q3 		$676K Buy
31,832
+769
+2% +$17.8K ﹤0.01% 4414
2023
Q2 		$838K Buy
31,063
+28,105
+950% +$685K ﹤0.01% 4392
2023
Q1 		$58.2K Sell
2,958
-9,049
-75% -$161K ﹤0.01% 6328
2022
Q4 		$163K Buy
12,007
+7,157
+148% +$104K ﹤0.01% 5634
2022
Q3 		$84K Buy
4,850
+1,105
+30% +$17.7K ﹤0.01% 5863
2022
Q2 		$49K Sell
3,745
-422
-10% -$7.03K ﹤0.01% 5934
2022
Q1 		$95K Sell
4,167
-6,883
-62% -$143K ﹤0.01% 5971
2021
Q4 		$245K Buy
11,050
+10,844
+5,264% +$233K ﹤0.01% 5516
2021
Q3 		$4K Buy
206
+155
+304% +$3.92K ﹤0.01% 8676
2021
Q2 		$2K Sell
51
-7,977
-99% -$258K ﹤0.01% 8976
2021
Q1 		$255K Buy
8,028
+2,269
+39% +$69.8K ﹤0.01% 5312
2020
Q4 		$172K Buy
5,759
+5,188
+909% +$126K ﹤0.01% 5329
2020
Q3 		$13K Sell
571
-8,995
-94% -$179K ﹤0.01% 6646
2020
Q2 		$152K Sell
9,566
-1,718
-15% -$27.1K ﹤0.01% 4997
2020
Q1 		$135K Sell
11,284
-8,711
-44% -$160K ﹤0.01% 5033
2019
Q4 		$430K Buy
19,995
+8,292
+71% +$149K ﹤0.01% 4969
2019
Q3 		$206K Buy
11,703
+6,965
+147% +$133K ﹤0.01% 5226
2019
Q2 		$96K Buy
4,738
+4,614
+3,721% +$79.2K ﹤0.01% 5403
2019
Q1 		$2K Sell
124
-3,891
-97% -$75.3K ﹤0.01% 7467
2018
Q4 		$84K Buy
+4,015
New +$76K ﹤0.01% 5680

Other funds holding SIBN

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

UBS Group's SIBN Position: Q1 2026 in Review

UBS Group reduced its SI-BONE Inc (SIBN) stake by 54% in Q1 2026, selling an estimated $884K and leaving 48,251 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #5938.

UBS Group first reported a position in SIBN in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.32M in Q2 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

  • UBS Group held 48,251 shares of SI-BONE Inc worth $609K as of Q1 2026.
  • UBS Group sold 56,480 SI-BONE Inc shares in Q1 2026, an estimated $884K.
  • SI-BONE Inc made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5938 holding.
  • UBS Group first reported a position in SI-BONE Inc in Q4 2018 and has held it in 30 quarters since.
  • UBS Group's SI-BONE Inc position peaked at $2.32M in Q2 2025.
  • 180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.